search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size
  • View All Access & Reimbursement 2016

  • Search More 2016
    12/16/2016

    IDSA Comments on the Medicare Final Rule for the Quality Payment Program

    IDSA provides comments on the Medicare Final Rule for the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Programs, collectively known as the Quality Payment Program (QPP). Specifically, IDSA provides further specifics on improvement activities (IAs), virtual groups, hospital-based physicians, and quality and cost measurement int he Medicare QPP.
    12/16/2016

    IDSA Joins Letter to President-elect on Need for Improved Reimbursement (PDF)

    Cognitive specialty groups, including IDSA, wrote to President-elect Trump asking that research move forward to improve the reimbursement of evaluation and management services through Medicare.
    10/12/2016

    IDSA Jointly Provides Comments to CMS on the Sepsis National Hospital Inpatient Quality Measure

    In collaboration with the American College of Emergency Physicians, the Society of Critical Care Medicine, and the Society of Hospital Medicine, IDSA jointly submitted a letter to the Center for Medicare and Medicaid Services (CMS) expressing our concerns with the antibiotics listed for the Sepsis National Hospital Inpatient Quality Measure (SEP-1) and provided recommendations towards addressing the issue. 

    09/06/2016

    IDSA Jointly Comments on the CY2017 Medicare Physician Fee Schedule Proposed Rule

    As a member of the Cognitive Care Alliance, IDSA jointly comments on the CY2017 Physician Fee Schedule Propose Rule. Specifically, comments are provided on the collection of data on resources used in furnishing global services as well as improving payment accuracy for primary care, care management, and patient centered services.
    09/06/2016

    IDSA Comments on the CY2017 Medicare Physician Fee Schedule Proposed Rule

    IDSA provides comments on the Medicare Physician Fee Schedule (MPFS) Proposed Rule for calendar year 2017 regarding medicare telehealth services, non-face-to-face prolonged evaluation and management (E/M) services, improving payment accuracy for primary care, care management, and patient centered services, valuation of the global surgery codes, and proposed expansion of the diabetes prevention program (DPP) model.
    08/15/2016

    IDSA Jointly Comments on Medicare and Medicaid Programs' Condition of Participation for Antimicrobial Stewardship

    IDSA, in collaboration with SHEA, jointly provides comments on the proposed rule regarding Medicare and Medicaid Programs; Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvement in Patient Care. The comment letter stresses the importance of antimicrobial stewardship programs (ASPs) and IDSA and SHEA's strong support of the proposal to require ASPs at acute care and critical access hospitals (CAHs). Furthermore, we provide comments on leadership of ASPs, ASP leadership's separate designation from infection preventionist/infection control professionals, ASPs measures of success, and tele-stewardship models to serve CAHs.  
    08/15/2016

    IDSA Comments on the Medicare and Medicaid Programs, Hospital and Critical Access Hospital Changes to Promote Innovation, Flexibility, and Improvement in Patient Care

    IDSA provides comments on the proposed regulation regarding Medicare and Medicaid Programs; Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvement in Patient Care. The comment letter stresses the importance of infectious diseases physician leadership in infection control and prevention programs as well as strongly supporting proposed changes relating to adherence to national infection prevention and control guidelines, organizational accountability for healthcare acquired infections (HAIs), responsibilities of the infection preventionist/infection control professional, and medical record services.
    07/22/2016

    IDSA Jointly Comments on the Veterans Health Administration's Advanced Practice Registered Nurses Proposed Rule

    In cooperation with many physician organizations representing national specialty and state medical societies, IDSA jointly provides comments on the Veterans Health Administration's (VHA) Advanced Practice Registered Nurses (APRNs) Proposed Rule. The comments strongly oppose the proposed rule and urge the VHA to consider policy alternatives that prioritize team-based care rather than independent nursing practice.
    07/12/2016

    IDSA Recommendations to Senate Finance Committee on MACRA (PDF)

    IDSA recommendations to the Senate Finance Committee for the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, including the need for new infectious diseases (ID) quality measures and ways to better align new physician quality improvement programs with antibiotic stewardship and public health emergency preparedness.  IDSA also highlighted the current undervaluation of the ID specialty and the steep decline in the number of physicians pursuing ID.
    06/27/2016

    IDSA Comments on the Merit Based Incentive Payment System and Alternative Payment Model Incentive Under the Physician Fee Schedule

    IDSA provides comments on the Merit Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive under the Physician Fee Schedule regarding the impact of the new quality payment program on the specialty of infectious diseases. Specifically, comments are provided on quality measures under MIPS, hospital-based physicians, development and implementation of quality measures, submission mechanisms, reporting on outcomes and high priority measures, threshold for data completeness, clarification on scoring of quality measurement under MIPS, specialty-specific measures, quality clinical data registries (QCDRs), virtual groups, quality performance period, and APMs. Furthermore, IDSA provides suggestions for clinical practice improvement activities (CPIAs) under MIPS that include antimicrobial stewardship programs, emergency response and preparedness, telehealth services, and CME.
    06/24/2016

    IDSA Jointly Comments on the MACRA Proposed Rule

    IDSA jointly comments on the implementation of the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) under the Medicare Access and CHIP Reauthorization Act (MACRA). The comments seeks to simplify the proposed MIPS program to ensure that is facilitates meaningful opportunities for performance improvement while decreasing administrative and compliance burdens, provide a more robust APM pathway that can support physicians who want to make the transition to new delivery and payment models, and accommodate the needs of physicians in rural, solo, or small practices in order to enhance their opportunities for success and avoid unintended consequences.
    06/07/2016

    IDSA Comments on the FY 2017 Inpatient Prospective Payment System Proposed Rule

    IDSA provides comments on the FY 2017 Inpatient Prospective Payment System (IPPS) proposed rule specifically regarding the Inpatient Quality Reporting (IQR) Program, sociodemographic (SDS) factors for quality measures, and the National Healthcare Safety Network (NHSN) Antimicrobial Use measure.
    06/03/2016

    IDSA Provides Comments on the RFI Assessing Interoperability for the MACRA

    IDSA jointly provides comments on the request for information (RFI) assessing interoperability for the Medicare Access and CHIP Reauthorization Act (MACRA). The comment letter express concern with the proposed use of current Meaningful Use (MU) program measures in the new Advancing Care Information (ACI) category within MACRA and recommends that the Office of the National Coordinator for Health Information Technology (ONC) and the Center for Medicare and Medicaid Services (CMS) collaboratively develop a list of proxy measures or metrics to capture valid, useful interoperability.
    05/26/2016

    IDSA provides comment on the FDA draft guidance for use of FMT to treat recurrent CDI

    IDSA responds the latest draft guidance issued by the FDA related to the use of FMT to treat recurrent CDI. In this draft guidance, the FDA has outlined its enforcement policy regarding IND requirements for FMT when use to treat RCDI. IDSA advocates for a finalized guidance that does not impose administrative burden on physicians who treat patients with RCDI with FMT.
    04/18/2016

    IDSA Joins Other Medical Societies to Raise Awareness of Physicians’ Concerns Regarding the Implementation of MACRA

    IDSA jointly expresses concerns regarding the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA). More specifically, comments are provided on the following overarching issues, ensuring that the implementation of MACRA does not disrupt the positive effect Alternative Payment Models (APMs) are having on beneficiaries' health in the public and private sector,  the need for a clear pathway for private sector models to meet the threshold for qualifying APMs under MACRA, virtual groups in the Merit-Based Incentive Payment System (MIPS) should be defined to help small, independent physician practices remain viable, and existing clinical quality improvement activities should satisfactorily meet MIPS requirements.
    02/09/2016

    IDSA Comments on 2016 Physician Quality Reporting System Feedback and Informal Review Processes

    IDSA has joined the AMA and 45 other medical societies in expressing concerns with the Centers for Medicare and Medicaid Services' inadequate feedback and informal review request processes. Specifically, the societies state issues with incomplete and inconsistent feedback, the lack of recourse for vendor transmission issues, inadequate assistance from QualityNet Help Desk, and the faulty informal review process.
    01/21/2016

    IDSA Letter to House Oversight Committee on Drug Pricing

    In advance of the House Government Oversight and Reform Committee hearing “Developments in the Prescription Drug Market,” IDSA sent a letter to Committee leaders related to broader issues regarding access to existing and new therapies for preventing and treating infectious diseases.

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site